冠心汤治疗气虚血瘀型冠心病介入术后残余病变心绞痛的临床研究
Clinical Study of Guanxin Decoction in the Treatment of Residual Lesions Angina Pectoris After Percutaneous Coronary Intervention in Coronary Heart Disease Patients with Qi Deficiency and Blood Stasis Pattern
-
摘要: 目的 观察本院自制汤剂冠心汤对气虚血瘀型冠心病介入术(PCI)后残余病变心绞痛患者的临床治疗效果。方法 将100例气虚血瘀型冠心病介入术后残余病变心绞痛患者随机分为对照组和冠心汤组,对照组(50例)给予常规西药方案(阿司匹林、氯吡格雷、阿托伐他汀钙、美托洛尔、单硝酸异山梨酯等),冠心汤组(50例)在对照组用药基础上加服冠心汤,疗程3个月。比较治疗前后超敏C反应蛋白(hs-CRP)、脂代谢(TC、HDL-C、LDL-C)和心肌缺血总负荷(TIB)的水平,观察患者生活质量评分(SF-36)、心绞痛复发率、西雅图心绞痛量表(SAQ)、中医证候积分疗效变化。结果 治疗后2组患者在心绞痛复发率、西雅图心绞痛量表、生活质量评分、中医证候积分疗效等方面较前改善(P<0.05~0.01),冠心汤组优于对照组(P<0.05~0.01);治疗后冠心汤组的中医证候有效率较对照组高(P<0.01)。2组hs-CRP、TC、LDL-C均显著下降(P<0.05~0.01),冠心汤组降低更明显(P<0.05~0.01);2组HDL-C水平均高于治疗前(P<0.05),但2组间比较无统计学差异(P>0.05)。2组TIB均较前降低(P<0.05~0.01),冠心汤组降低更为显著(P<0.05)。结论 冠心汤可有效改善气虚血瘀型冠心病PCI后残余病变心绞痛患者的临床症状,减轻心肌缺血,调节血脂代谢,减少炎症反应,提高生活质量。Abstract: OBJECTIVE To observe the clinical effect of Guanxin Decoction in the treatment of residual lesions angina pectoris after percutaneous coronary intervention (PCI) in Percutaneous Coronary Intervention (CHD) patients with qi deficiency and blood stasis pattern. METHODS 100 CHD patients of qi deficiency and blood stasis pattern with residual lesions angina pectoris after PCI were randomly divided into the control group and Guanxin Decoction group. The control group (50 cases) was given conventional Western medicine, like aspirin, clopidogrel, atorvastatin calcium, metoprolol, isosorbide mononitrate, while Guanxin Decoction group (50 cases) was added with Guanxin Decoction on the basis of control group therapy. The therapeutic course was 3 months. The levels of hypersensitive C-reactive protein (hs-CRP), lipid metabolism (TC, HDL-C, LDL-C) and total ischemia burden (TIB) were compared before and after treatment. The integral quality of life (SF-36), recurrence rate and degree of angina pectoris, Seattle angina questionnaire (SAQ) and TCM syndrome scores were observed. The results were analyzed by SPSS 20.0. RESULTS The recurrence rate and degree of angina, SAQ, SF-36 and TCM syndrome scores of the two groups were improved after treatment (P<0.05, P<0.01), and the effect of Guanxin Decoction group was better than that of the control group (P<0.05, P<0.01). The levels of hs-CRP, TC and LDL-C in the two groups were lower than those before treatment (P<0.05, P<0.01), and the effect of Guanxin Decoction group was much more significant (P<0.05, P<0.01). The level of HDL-C in the two groups was higher than that before treatment (P<0.05), but there was no difference between the two groups (P>0.05). The level of TIB in the two groups were lower than before (P<0.05, P<0.01), and the decrease in Guanxin Decoction group was more significant (P<0.05). CONCLUSION Guanxin Decoction can effectively improve the clinical effect in treating residual lesions angina pectoris after PCI in CHD patients with qi deficiency and blood stasis syndrome, relieving myocardial ischemia, regulating blood lipid metabolism, reducing inflammatory response, and improving patients' quality of life.
-
[1] GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: A systematic analysis for the Global Burden of Disease Study 2015[J].Lancet,2016,388(10059): 1459-1544. [2] 周函,徐健,黄文胜,等.稳定型心绞痛和不稳定型心绞痛与同型半胱氨酸水平的相关性[J].中国老年学杂志,2016,36(9):2099-2101. [3] 范宗静,崔杰,吴旸,等.冠心病患者介入治疗前后证候的分布及演变规律探析[J].时珍国医国药,2013,24(12):3016-3017. [4] 张大武,王承龙,王培利,等.益气活血中药干预介入后急性冠脉综合征患者的中医证候演变[J].中西医结合心脑血管病杂志,2013,11(4):385-388. [5] 杨巧宁,谷丰,高铸烨,等.介入治疗后ACS患者中医证候要素分布特征的现况调查[J].中国中医急症,2014,23(1): 6-7. [6] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.非ST段抬高急性冠状动脉综合征诊断和治疗指南[J].中华心血管病杂志,2012,40(5):353-367. [7] 中华人民共和国卫生部.中药新药治疗胸痹(冠心病心绞痛)的临床研究指导原则[M].北京:中国医药科技出版社,2002:41-44. [8] 国家卫生计生委合理用药专家委员会,中国药师协会. 冠心病合理用药指南[J]. 中国医学前沿杂志(电子版),2016,8(6):19-107. [9] 冯仁余,李七一.中医药治疗冠心病概况[J].长春中医药大学学报,2013,29(3): 544-545. [10] 陈伟,王风利,王晶.川芎配伍应用偶得[J].河南中医,2005,25(4):69-70. [11] 卓微伟.中药白及的药理作用及临床应用的研究进展[J].北方药学,2014,11(11):69. [12] 黄兴,王哲,王保和.仙鹤草药理作用及临床应用研究进展[J].山东中医杂志,2017,36(2):172-176. [13] 杨红庆,姜文锡,梅换明,等.纤维蛋白原与超敏C反应蛋白在冠心病患者中的表达与意义[J].中国老年学杂志,2013,33(21): 5293-5294. [14] 朱旭,郑利平.冠心病患者血清超敏C反应蛋白、肌钙蛋白、血脂水平变化及临床意义[J].中国实验方剂学杂志,2012,18(7):258-260. [15] 中国成人血脂异常防治指南修订联合委员会.中国成人血脂异常防治指南(2016年修订版)[J].中国循环杂志,2016,31(10):937-953. [16] 于洋,田俊萍,杜凤和.动态心电图在冠心病中的应用价值[J].心血管病学进展,2015,36(6):695-699.
点击查看大图
计量
- 文章访问数: 1156
- HTML全文浏览量: 13
- PDF下载量: 550
- 被引次数: 0